Novartis's Ultibro Breezhaler receives EC, Japanese nod

Singapore: Novartis has announced that the European Commission has approved once-daily Ultibro Breezhaler (indacaterol 8...

September 26, 2013 | Thursday | News
Shimadzu India aims at 15-20% growth

With a view of expanding their customer base, Shimadzu Analytical India has been taking concrete steps towards connectin...

October 29, 2012 | Monday | Influencers
Ex-GSK boss promoted as Takeda's CEO

Singapore: Japan's Takeda Pharmaceutical has promoted Mr Christophe Weber, representative director, president and chief ...

April 24, 2014 | Thursday | Influencers
Millennium starts ph III trial for multiple myeloma drug

Singapore: Millennium: The Takeda Oncology Company, has initiated an international phase III clinical trial evaluating M...

July 2, 2012 | Monday | News
Astellas looks to sell dermatology assets: Sources

Singapore: Japan-based drugmaker Astellas Pharma is planning to sell its dermatology portfolio, which could be worth bet...

June 19, 2013 | Wednesday | News
SymBio Pharma completes patient enrollment

Singapore: Japan-headquartered SymBio Pharmaceuticals has completed patient enrollment for its phase II clinical trial o...

March 8, 2013 | Friday | News
OMRON reports performance for Q1 2012

Singapore: OMRON Corporation reported consolidated performance for the first quarter (Q1) of fiscal 2012, which included...

August 1, 2012 | Wednesday | Company results
International consortium sequences tomato genome

Singapore: The Tomato Genome Consortium (TGC), which is a group of over 300 scientists from 13 countries sequenced the g...

June 1, 2012 | Friday | News
Japan approves world's first transdermal ß1-blocker patch

Singapore: Japan-based Nitto Denko announced that Toa Eiyo has received manufacturing and marketing authorization in Jap...

July 5, 2013 | Friday | Regulatory
Eisai, Toyama get marketing approval for iguratimod

Singapore: Eisai and Toyama Chemical have received approval from Japan's Ministry of Health, Labour and Welfare to marke...

July 2, 2012 | Monday | Regulatory
Daiichi to launch Inavir anti-influenza product in Japan

Singapore: Daiichi Sankyo submitted an application for a partial label change in Japan to manufacture and market the inf...

November 16, 2012 | Friday | News
FDA slams Shionogi for eyeing profit over patient safety

Singapore: The FDA had during September 2012 informed Shionogi that it need to conduct two clinical trials in order to e...

May 30, 2013 | Thursday | Regulatory
Medical laser market to reach $8.8 bn by 2018: GIA

Singapore: Technological advancements in laser technology have created a plethora of applications in the medical field, ...

July 19, 2013 | Friday | News
Chugai, Nippon Shinyaku tie up for drug development

Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co...

December 6, 2012 | Thursday | News
INC Research opens two new offices in Japan

Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R)...

July 30, 2013 | Tuesday | News
Deregulation will boost Japanese pharma sector

Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent o...

June 4, 2013 | Tuesday | News
Takeda gets FDA nod for three diabetes drugs

Singapore: Japan-headquartered Takeda Pharmaceutical received the US Food and Drug Administration (FDA) approval for Nes...

February 4, 2013 | Monday | News
Teva appoints new chairman for Japan, South Korea

Singapore: Teva Pharmaceutical has appointed Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and...

September 13, 2012 | Thursday | News